OSSICA

Medicinal product

(Invented) name

OSSICA

Active substance (s)

Ibandrono rūgštis

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M05BA06, Ibandronic acid

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-02-14

Date of renewal

Documents

2377_OSSICA_150_pl_d_tab_N1_N3_PIL.docx

2377_OSSICA_150_pl_d_tab_N1_N3_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Ibandrono rūgštis	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116689	102789	1102789	lizdinė plokštelė	N1		Receptinis	LT/L/25/2377/001	Netiekiama	-	2025-07-22	No	-	-	Download
116692	102793	1102793	lizdinė plokštelė	N3		Receptinis	LT/L/25/2377/002	Netiekiama	-	2025-06-30	No	-	-

Stadijos

Data	Stadija
2025-02-14	Registruotas